相关实验视频

Updated: Jul 17, 2025

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Published on: April 20, 2018

在社区瘤学环境中,对本地晚期HNSCC患者的现实研究

Christopher M Black¹, Karthik Ramakrishnan¹, Eric Nadler^2,3

¹Center for Observational and Real-World Evidence, Merck & Co., Inc., Rahway, NJ, United States.

Frontiers in oncology

|September 4, 2023

概括

这项研究分析了用化学辐射疗法治疗本地晚期头角状细胞癌 (HNSCC) 患者的现实数据. 西斯普拉丁加放射治疗是常见的,但塞图西马布加放射治疗显示出更长的生存潜力,特别是在HPV阳性口腔癌中.

科学领域:

在瘤学瘤学.
头部和部癌症研究研究
临床数据分析临床数据分析

背景情况:

局部发达的头部和部状细胞癌 (HNSCC) 需要了解当前的现实世界治疗模式.
化学辐射疗法 (CRT) 是一种标准治疗方法,但结果各不相同.

研究的目的:

评估接受CRT的局部晚期HNSCC患者的现实结果和治疗模式.
建立未来社区瘤学研究的基准.

主要方法:

对1,158名患有III-IVB阶段HNSCC开始CRT的成年患者的回顾性分析 (2015年1月至2017年12月).
从美国社区瘤实践中的电子健康记录中抽取的数据.
分析治疗模式 (西斯普拉丁+RT,西斯普拉丁+其他化疗+RT, cetuximab+RT) 和生存结果 (TTNT,OS).

主要成果:

西斯普拉丁+RT是最常见的并发化疗 (65.8%).
到下一次治疗的中位时间 (TTNT) 和整体存活率 (OS) 仅在 cetuximab + RT 队列中达到.
人类乳头瘤病毒 (HPV) 阳性口腔癌患者的治疗持续时间更长,60个月的存活率更高.
与从未使用/以前使用烟草,HPV阳性和较高的BMI相关的更好的生存率;60岁以上的低喉/口腔瘤和ECOG PS 2+的较差生存率.

结论:

描述了用CRT治疗局部晚期HNSCC的现实世界治疗模式.
数据为未来的社区瘤学研究提供了基线.
塞图西马布+RT可能在特定的患者亚组中提供生存益处.

关键词:

在CRT中,CRT可以在CRT中使用.这是一个HPVHPVHPV.癌症治疗模式癌症治疗模式同时进行化疗与放射治疗.头部和部癌症头部和部癌症在本地先进的先进.结果就是结果.现实世界的真实世界.

更多相关视频

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

A Model for Perineural Invasion in Head and Neck Squamous Cell Carcinoma

A Model for Perineural Invasion in Head and Neck Squamous Cell Carcinoma

Published on: January 5, 2017

相关概念视频

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...